Meera Chand
#137,147
Most Influential Person Now
British microbiologist
Meera Chand's AcademicInfluence.com Rankings
Meera Chandbiology Degrees
Biology
#14917
World Rank
#18795
Historical Rank
Microbiology
#975
World Rank
#1080
Historical Rank
Neuroscience
#2667
World Rank
#2737
Historical Rank
Download Badge
Biology
Meera Chand's Degrees
- Bachelors Microbiology University of Oxford
- Masters Microbiology University of Oxford
Why Is Meera Chand Influential?
(Suggest an Edit or Addition)According to Wikipedia, Meera A. Chand is a British microbiologist, working at Public Health England and as a consultant with the Department of Infectious Diseases, Guy's and St Thomas' NHS Foundation Trust. She is also a clinical research fellow into severe acute respiratory infections at Imperial College London.
Meera Chand's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant (2021) (1868)
- Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant (2022) (995)
- Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity (2020) (819)
- Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England (2021) (806)
- Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers (2020) (706)
- SARS-CoV-2 evolution during treatment of chronic infection (2021) (647)
- Transmission of SARS-CoV-2 Lineage B.1.1.7 in England: Insights from linking epidemiological and genetic data (2021) (557)
- Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study (2022) (515)
- Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study (2022) (515)
- Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study (2021) (488)
- Severe respiratory illness caused by a novel coronavirus, in a patient transferred to the United Kingdom from the Middle East, September 2012. (2012) (473)
- Mapping the human genetic architecture of COVID-19 (2021) (455)
- COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study (2021) (423)
- COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study (2021) (423)
- SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN) (2021) (415)
- SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN) (2021) (415)
- Duration of Protection against Mild and Severe Disease by Covid-19 Vaccines (2022) (307)
- Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7 (2021) (285)
- Protection against SARS-CoV-2 after Covid-19 Vaccination and Previous Infection (2022) (259)
- Two cases of monkeypox imported to the United Kingdom, September 2018 (2018) (229)
- Effectiveness of COVID-19 vaccines against the B.1.617.2 variant (2021) (228)
- Human-to-Human Transmission of Monkeypox Virus, United Kingdom, October 2018 (2020) (226)
- Effectiveness of COVID-19 vaccines against the Omicron (B.1.1.529) variant of concern (2021) (215)
- Community transmission of monkeypox in the United Kingdom, April to May 2022 (2022) (195)
- Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine (2021) (191)
- Global outbreak of severe Mycobacterium chimaera disease after cardiac surgery: a molecular epidemiological study. (2017) (166)
- Exportation of Monkeypox Virus From the African Continent (2020) (148)
- Effectiveness of BNT162b2 mRNA Vaccine Against Infection and COVID-19 Vaccine Coverage in Healthcare Workers in England, Multicentre Prospective Cohort Study (the SIREN Study) (2021) (139)
- Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort study (2021) (136)
- SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway (2022) (130)
- Vaccine effectiveness and duration of protection of Comirnaty, Vaxzevria and Spikevax against mild and severe COVID-19 in the UK (2021) (127)
- Insidious Risk of Severe Mycobacterium chimaera Infection in Cardiac Surgery Patients (2017) (115)
- Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study (2021) (98)
- Resurgence of scarlet fever in England, 2014-16: a population-based surveillance study. (2017) (95)
- Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the ISARIC WHO Clinical Characterisation Protocol UK (2021) (94)
- Changing composition of SARS-CoV-2 lineages and rise of Delta variant in England (2021) (93)
- COVID-19 vaccine effectiveness against the omicron (BA.2) variant in England (2022) (91)
- Exponential growth, high prevalence of SARS-CoV-2, and vaccine effectiveness associated with the Delta variant (2021) (82)
- Investigation of SARS-CoV-2 outbreaks in six care homes in London, April 2020 (2020) (80)
- Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study (2021) (77)
- The United Kingdom public health response to an imported laboratory confirmed case of a novel coronavirus in September 2012. (2012) (75)
- High prevalence of SARS-CoV-2 antibodies in care homes affected by COVID-19: Prospective cohort study, England (2020) (69)
- Increased risk of SARS-CoV-2 infection in staff working across different care homes: enhanced CoVID-19 outbreak investigations in London care Homes (2020) (68)
- Pneumococcal serotype trends, surveillance and risk factors in UK adult pneumonia, 2013–18 (2019) (64)
- Microbiological problems and biofilms associated with Mycobacterium chimaera in heater-cooler units used for cardiopulmonary bypass. (2017) (62)
- Detection of neutralising antibodies to SARS-CoV-2 to determine population exposure in Scottish blood donors between March and May 2020 (2020) (60)
- Antibodies to SARS-CoV-2 are associated with protection against reinfection (2020) (60)
- Genomic reconstruction of the SARS-CoV-2 epidemic in England (2021) (59)
- Changes in in-hospital mortality in the first wave of COVID-19: a multicentre prospective observational cohort study using the WHO Clinical Characterisation Protocol UK (2021) (56)
- Mycobacterium chimaera infection following cardiac surgery in the United Kingdom: clinical features and outcome of the first 30 cases. (2018) (55)
- An observational cohort study on the incidence of SARS-CoV-2 infection and B.1.1.7 variant infection in healthcare workers by antibody and vaccination status (2021) (54)
- Genome analysis following a national increase in Scarlet Fever in England 2014 (2017) (54)
- T-cell and antibody responses to first BNT162b2 vaccine dose in previously infected and SARS-CoV-2-naive UK health-care workers: a multicentre prospective cohort study (2021) (51)
- T-cell and antibody responses to first BNT162b2 vaccine dose in previously infected and SARS-CoV-2-naive UK health-care workers: a multicentre prospective cohort study (2021) (51)
- COVID-19 symptoms at hospital admission vary with age and sex: results from the ISARIC prospective multinational observational study (2021) (49)
- An Observational Cohort Study on the Incidence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and B.1.1.7 Variant Infection in Healthcare Workers by Antibody and Vaccination Status (2021) (43)
- International Society of Cardiovascular Infectious Diseases Guidelines for the Diagnosis, Treatment and Prevention of Disseminated Mycobacterium chimaera Infection Following Cardiac Surgery with Cardiopulmonary Bypass. (2019) (42)
- Non-steroidal anti-inflammatory drug use and outcomes of COVID-19 in the ISARIC Clinical Characterisation Protocol UK cohort: a matched, prospective cohort study (2021) (42)
- The origins and molecular evolution of SARS-CoV-2 lineage B.1.1.7 in the UK (2022) (39)
- Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies (2021) (37)
- Large-scale sequencing of SARS-CoV-2 genomes from one region allows detailed epidemiology and enables local outbreak management (2020) (37)
- T-Cell and Antibody Responses to First BNT162b2 Vaccine Dose in Previously SARS-CoV-2-Infected and Infection-Naive UK Healthcare Workers: A Multicentre, Prospective, Observational Cohort Study (2021) (37)
- Probable Vertical Transmission of SARS-CoV-2 Infection (2020) (34)
- Snapshot PCR surveillance for SARS-CoV-2 in hospital staff in England (2020) (31)
- EU protocol for case detection, laboratory diagnosis and environmental testing of Mycobacterium chimaera infections potentially associated with heater-cooler units: case definition and environmental testing methodology (2015) (27)
- Comparative Analysis of the Risks of Hospitalisation and Death Associated with SARS-CoV-2 Omicron (B.1.1.529) and Delta (B.1.617.2) Variants in England (2022) (27)
- Context-specific emergence and growth of the SARS-CoV-2 Delta variant (2021) (26)
- Imported Human Fascioliasis, United Kingdom (2009) (20)
- Adeno-associated virus 2 infection in children with non-A-E hepatitis (2022) (20)
- Effectiveness and durability of protection against future SARS-CoV-2 infection conferred by COVID-19 vaccination and previous infection; findings from the UK SIREN prospective cohort study of healthcare workers March 2020 to September 2021 (2021) (20)
- The role of viral genomics in understanding COVID-19 outbreaks in long-term care facilities (2021) (20)
- The changing epidemiology of diphtheria in the United Kingdom, 2009 to 2017 (2020) (19)
- An early warning system for emerging SARS-CoV-2 variants (2022) (19)
- Assessment of Mortality and Hospital Admissions Associated with Confirmed Infection with SARS-CoV-2 Variant of Concern VOC-202012/01 (B.1.1.7) a Matched Cohort and Time-to-Event Analysis (2021) (18)
- The value of open-source clinical science in pandemic response: lessons from ISARIC (2021) (17)
- The UK's multidisciplinary response to an Ebola epidemic. (2017) (16)
- Publisher Correction: SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway (2022) (15)
- Genomic reconstruction of the SARS-CoV-2 epidemic across England from September 2020 to May 2021 (2021) (15)
- Importance of patient bed pathways and length of stay differences in predicting COVID-19 hospital bed occupancy in England (2021) (14)
- A case of avian influenza A(H5N1) in England, January 2022 (2022) (14)
- SARS-CoV-2 infection in London, England: changes to community point prevalence around lockdown time, March–May 2020 (2020) (13)
- Microbiological aspects of public health planning and preparedness for the 2012 Olympic Games (2012) (12)
- Context-specific emergence and growth of the SARS-CoV-2 Delta variant (2022) (12)
- Implementation of corticosteroids in treatment of COVID-19 in the ISARIC WHO Clinical Characterisation Protocol UK: prospective, cohort study (2022) (10)
- SIREN protocol: Impact of detectable anti-SARS-CoV-2 on the subsequent incidence of COVID-19 in 100,000 healthcare workers: do antibody positive healthcare workers have less reinfection than antibody negative healthcare workers? (2020) (10)
- Persistence of SARS-CoV-2 N-Antibody Response in Healthcare Workers, London, UK (2021) (9)
- An integrated analysis of contact tracing and genomics to assess the efficacy of travel restrictions on SARS-CoV-2 introduction and transmission in England from June to September, 2020 (2021) (9)
- New Public Health England guidelines for managing pertussis in England. (2017) (8)
- Legionella antibiotic susceptibility testing: is it time for international standardization and evidence-based guidance? (2021) (8)
- Transmission of toxigenic Corynebacterium diphtheriae by a fully immunised resident returning from a visit to West Africa, United Kingdom, 2017 (2018) (8)
- Distinct clinical symptom patterns in patients hospitalised with COVID-19 in an analysis of 59,011 patients in the ISARIC-4C study (2022) (7)
- Development and evaluation of a nanopore 16S rRNA gene sequencing service for same day targeted treatment of bacterial respiratory infection in the intensive care unit. (2021) (7)
- Serological profile of first SARS-CoV-2 reinfection cases detected within the SIREN study (2021) (7)
- Hepatitis of unknown aetiology in children – epidemiological overview of cases reported in Europe, 1 January to 16 June 2022 (2022) (7)
- Hospitalisation and mortality risk of SARS-COV-2 variant omicron sub-lineage BA.2 compared to BA.1 in England (2022) (7)
- Genomic assessment of quarantine measures to prevent SARS-CoV-2 importation and transmission (2022) (6)
- Comparison of the risk of hospitalisation among BA.1 and BA.2 COVID-19 cases treated with Sotrovimab in the community in England (2022) (6)
- Cloth Lanyards as a Source of Intermittent Transmission of Candida auris on an ICU. (2021) (6)
- Antibody correlates of protection from SARS-CoV-2 reinfection prior to vaccination: A nested case-control within the SIREN study (2022) (5)
- Effectiveness of the COVID-19 vaccines against hospitalisation with Omicron sub-lineages BA.4 and BA.5 in England (2022) (5)
- Antiviral drug resistance and the use of directly acting antiviral drugs (DAAs) for COVID-19 (2021) (5)
- A sticky case of intestinal obstruction (2007) (5)
- Evidence that Mycobacterium chimaera aerosols penetrate laminar airflow and result in infections at the surgical field. (2017) (5)
- Genomic epidemiology of SARS-CoV-2 in a UK university identifies dynamics of transmission (2022) (5)
- Possible contamination of organ preservation fluid with Bacillus cereus: the United Kingdom response. (2012) (5)
- Impact of prior SARS-CoV-2 infection and COVID-19 vaccination on the subsequent incidence of COVID-19: a multicentre prospective cohort study among UK healthcare workers – the SIREN (Sarscov2 Immunity & REinfection EvaluatioN) study protocol (2022) (4)
- Assessment of mortality and hospital admissions associated with confirmed infection with SARS-CoV-2 Alpha variant: a matched cohort and time-to-event analysis, England, October to December 2020 (2022) (4)
- SARS-CoV-2 infection in London, England: Impact of lockdown on community point-prevalence, March-May 2020 (2020) (4)
- Putative APOBEC3 deaminase editing in MPXV as evidence for sustained human transmission since at least 2016 (2023) (4)
- Hospitalization and Mortality Risk for COVID-19 Cases With SARS-CoV-2 AY.4.2 (VUI-21OCT-01) Compared to Non-AY.4.2 Delta Variant Sublineages (2022) (4)
- Characteristics and mortality of severe influenza cases treated with parenteral aqueous zanamivir, United Kingdom, October 2009 to January 2011 (2018) (4)
- Invasive Mycobacterium chimaera Infections and Heater–Cooler Devices in Cardiac Surgery (2020) (3)
- Genome-first detection of emerging resistance to novel therapeutic agents for SARS-CoV-2 (2022) (3)
- Use of cidofovir in a patient with severe mpox and uncontrolled HIV infection (2023) (3)
- Mycobacterium chimaera Isolates from Heater–Cooler Units, United Kingdom (2017) (3)
- Genomic assessment of invasion dynamics of SARS-CoV-2 Omicron BA.1 (2023) (2)
- Molecular epidemiology and antimicrobial resistance of Corynebacterium diphtheriae and Corynebacterium ulcerans strains isolated in the UK between 2004-2017 (2019) (2)
- The role of genomics in understanding COVID-19 outbreaks in long term care facilities (2020) (2)
- Investigation of hospital discharge cases and SARS-CoV-2 introduction into Lothian care homes (2023) (1)
- Genomic investigations of unexplained acute hepatitis in children. (2023) (1)
- Context-specific emergence and growth of the SARS-CoV-2 Delta variant (2021) (1)
- Respiratory support in patients with severe COVID-19 in the International Severe Acute Respiratory and Emerging Infection (ISARIC) COVID-19 study: a prospective, multinational, observational study (2022) (1)
- Symptom‐based case definitions for COVID‐19: Time and geographical variations for detection at hospital admission among 260,000 patients (2022) (1)
- Publisher Correction: Genomic reconstruction of the SARS CoV-2 epidemic in England (2021) (1)
- The dangers of itchy feet: Parasitic infections imported by returning travellers (2009) (0)
- Publisher Correction: Genomic reconstruction of the SARS CoV-2 epidemic in England (2022) (0)
- Overview of the conference (2013) (0)
- 657. Evaluation of Nanopore-Based 16S Ribosomal RNA (rRNA) Gene Sequencing for the Development of a Rapid Infection Intervention Clinical Service (2019) (0)
- Genome analysis following a national increase in Scarlet Fever in England 2014 (2017) (0)
- A Case Of Varicella-Zoster Virus In A Maternity Unit (2018) (0)
- Correction to: The origins and molecular evolution of SARS-CoV-2 lineage B.1.1.7 in the UK (2022) (0)
- Early Warning Surveillance for SARS-CoV-2 Omicron Variants, United Kingdom, November 2021–September 2022 (2022) (0)
- The P323L substitution in the SARS-CoV-2 polymerase (NSP12) confers a selective advantage during infection (2023) (0)
- Gastroenteritis Outbreaks in 2 Tourist Resorts , Dominican Republic (2019) (0)
- ISARIC-COVID-19 dataset: A Prospective, Standardized, Global Dataset of Patients Hospitalized with COVID-19 (2022) (0)
- Toxigenic Corynebacterium ulcerans: re-emergence of a zoonotic infection (2020) (0)
- Title: SARS-CoV-2 infection in London, England: Impact of lockdown on community point- (2020) (0)
- SARS-CoV-2 evolution during treatment of chronic infection (2021) (0)
- A Rising Africa is Good News for Africa (Interview) (2006) (0)
- Case Studies in Infection Control (2018) (0)
- The Imported Fever Service; a UK-wide system for improved management and diagnosis of fever in returned travellers (2013) (0)
This paper list is powered by the following services:
Other Resources About Meera Chand
What Schools Are Affiliated With Meera Chand?
Meera Chand is affiliated with the following schools:
